Nov 07, 2023 / 01:30PM GMT
Operator
Welcome to the ADC Therapeutics third-quarter 2023 financial results conference call. My name is Cathy, and I will be your operator for today's call. (Operator Instructions)
I'll now turn the call over to Eugenia Litz, Vice President of Investor Relations and Corporate Communications. Eugenia, you may now begin.
Eugenia Litz - ADC Therapeutics SA - VP, IR & Corporate Communications
Thank you, operator. This morning, we issued a press release announcing our third-quarter 2023 financial results and business update. This release is available on the ADCT website at ir.adctherapeutics.com under the Press Releases' section.
On today's call, Ameet Mallik, Chief Executive Officer; Kristen Harrington-Smith, Chief Commercial Officer; Mohamed Zaki, Chief Medical Officer; and Pepe Carmona, Chief Financial Officer, will discuss recent business highlights and review our third-quarter 2023 financial results before opening the call for questions.
Before we begin, I would like to remind listeners that some of the statements made during this
Q3 2023 ADC Therapeutics SA Earnings Call Transcript
Nov 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers